Pharmosa Biopharm Inc. (TPEX:6875)
Taiwan
· Delayed Price · Currency is TWD 47.30
+0.30 (0.64%)
Apr 24, 2025, 1:20 PM CST
Pharmosa Biopharm Market Cap
Pharmosa Biopharm has a market cap or net worth of 6.11 billion as of April 24, 2025. Its market cap has decreased by -48.93% in one year.
Market Cap
6.11B
Enterprise Value
4.60B
Revenue
167.57M
Ranking
n/a
PE Ratio
n/a
Stock Price
47.30
Market Cap Chart
Since February 22, 2022, Pharmosa Biopharm's market cap has increased from 4.86B to 6.11B, an increase of 25.68%. That is a compound annual growth rate of 7.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2025 | 6.11B | -10.59% |
| Dec 31, 2024 | 6.83B | -33.79% |
| Dec 29, 2023 | 10.31B | 46.19% |
| Dec 30, 2022 | 7.06B | 45.23% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 160.86B |
| Caliway Biopharmaceuticals | 93.54B |
| Bora Pharmaceuticals Co., LTD. | 69.42B |
| Lotus Pharmaceutical | 54.79B |
| Polaris Group | 28.88B |
| Oneness Biotech | 27.68B |
| Pegavision | 25.55B |
| Lumosa Therapeutics | 25.50B |